Mel Green - Publications

Affiliations: 
 

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Matosin N, Green MJ, Andrews JL, Newell KA, Fernandez-Enright F. Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function. Neuroreport. PMID 26555035 DOI: 10.1097/WNR.0000000000000491  0.398
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1. PMID 26537981 DOI: 10.1017/S0033291715002433  0.589
2015 Green MJ, Raudino A, Cairns MJ, Wu J, Tooney PA, Scott RJ, Carr VJ. Do common genotypes of FK506 binding protein 5 (FKBP5) moderate the effects of childhood maltreatment on cognition in schizophrenia and healthy controls? Journal of Psychiatric Research. 70: 9-17. PMID 26424418 DOI: 10.1016/j.jpsychires.2015.07.019  0.337
2015 Rodriguez-Jimenez R, Dompablo M, Bagney A, Santabárbara J, Aparicio AI, Torio I, Moreno-Ortega M, Lopez-Anton R, Lobo A, Kern RS, Green MF, Jimenez-Arriero MA, Santos JL, Nuechterlein KH, Palomo T. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning. Schizophrenia Research. PMID 26416441 DOI: 10.1016/J.Schres.2015.09.013  0.415
2015 Green MF, Horan WP, Lee J. Social cognition in schizophrenia. Nature Reviews. Neuroscience. PMID 26373471 DOI: 10.1038/Nrn4005  0.359
2015 Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2-External Validity and Correlates. Schizophrenia Bulletin. PMID 26209546 DOI: 10.1093/Schbul/Sbv090  0.487
2015 Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1-Psychometric Characteristics of 5 Paradigms. Schizophrenia Bulletin. PMID 26142081 DOI: 10.1093/Schbul/Sbv089  0.562
2015 Rose A, Vinogradov S, Fisher M, Green MF, Ventura J, Hooker C, Merzenich M, Nahum M. Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol. Bmc Psychiatry. 15: 142. PMID 26138715 DOI: 10.1186/S12888-015-0510-1  0.405
2015 Green MF, Horan WP. Effort-Based Decision Making in Schizophrenia: Evaluation of Paradigms to Measure Motivational Deficits. Schizophrenia Bulletin. PMID 26108868 DOI: 10.1093/Schbul/Sbv084  0.334
2015 Green MF, Horan WP, Barch DM, Gold JM. Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia. Schizophrenia Bulletin. PMID 26089350 DOI: 10.1093/Schbul/Sbv071  0.513
2015 Horan WP, Reise SP, Kern RS, Lee J, Penn DL, Green MF. Structure and correlates of self-reported empathy in schizophrenia. Journal of Psychiatric Research. 66: 60-6. PMID 25985922 DOI: 10.1016/J.Jpsychires.2015.04.016  0.459
2015 Rassovsky Y, Dunn W, Wynn J, Wu AD, Iacoboni M, Hellemann G, Green MF. The effect of transcranial direct current stimulation on social cognition in schizophrenia: A preliminary study. Schizophrenia Research. 165: 171-4. PMID 25934168 DOI: 10.1016/J.Schres.2015.04.016  0.398
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1-10. PMID 25916421 DOI: 10.1017/S0033291715000641  0.601
2015 Green MF, Llerena K, Kern RS. The "Right Stuff" Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia? Schizophrenia Bulletin. 41: 781-5. PMID 25750248 DOI: 10.1093/Schbul/Sbv018  0.38
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/J.Schres.2015.01.017  0.391
2015 Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, et al. A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Research. 164: 136-42. PMID 25728831 DOI: 10.1016/J.Schres.2015.01.041  0.423
2015 Jahshan C, Wynn JK, Mathis KI, Green MF. The neurophysiology of biological motion perception in schizophrenia. Brain and Behavior. 5: 75-84. PMID 25722951 DOI: 10.1002/Brb3.303  0.315
2015 Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, ... ... Green MF, et al. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophrenia Research. 163: 73-9. PMID 25682549 DOI: 10.1016/J.Schres.2015.01.027  0.333
2015 J?drasik-Sty?a M, Cio?kiewicz A, Sty?a R, Linke M, Parnowska D, Gruszka A, Denisiuk M, Jarema M, Green MF, Wichniak A. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties. The Psychiatric Quarterly. PMID 25601030 DOI: 10.1007/S11126-015-9343-9  0.509
2015 Wu JQ, Green MJ, Gardiner EJ, Tooney PA, Scott RJ, Carr VJ, Cairns MJ. Altered neural signaling and immune pathways in peripheral blood mononuclear cells of schizophrenia patients with cognitive impairment: A transcriptome analysis Brain, Behavior, and Immunity. DOI: 10.1016/j.bbi.2015.12.010  0.35
2015 Huang Y, Green MA. Detection and tracking of vortex phenomena using Lagrangian coherent structures Experiments in Fluids. 56. DOI: 10.1007/S00348-015-2001-Z  0.032
2014 Green MF, Harris JG, Nuechterlein KH. The MATRICS consensus cognitive battery: what we know 6 years later. The American Journal of Psychiatry. 171: 1151-4. PMID 25756630 DOI: 10.1176/Appi.Ajp.2014.14070936  0.311
2014 Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophrenia Research. 159: 182-7. PMID 25156338 DOI: 10.1016/J.Schres.2014.07.032  0.492
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia Research. 140: 1-8. PMID 22503642 DOI: 10.1016/J.Schres.2012.03.025  0.534
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophrenia Research. 140: 9-14. PMID 22503641 DOI: 10.1016/J.Schres.2012.03.026  0.507
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/J.Schres.2011.11.001  0.591
2011 Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychological Assessment. 23: 245-61. PMID 21381848 DOI: 10.1037/A0021501  0.567
2011 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophrenia Research. 126: 124-31. PMID 21159492 DOI: 10.1016/J.Schres.2010.11.008  0.592
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/J.Biopsych.2010.09.052  0.618
2010 Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophrenia Research. 121: 24-31. PMID 20542412 DOI: 10.1016/J.Schres.2010.04.016  0.578
2008 Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. The American Journal of Psychiatry. 165: 203-13. PMID 18172019 DOI: 10.1176/Appi.Ajp.2007.07010042  0.611
2008 Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. The American Journal of Psychiatry. 165: 214-20. PMID 18172018 DOI: 10.1176/Appi.Ajp.2007.07010043  0.563
2008 Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. The American Journal of Psychiatry. 165: 221-8. PMID 18172017 DOI: 10.1176/Appi.Ajp.2007.07010089  0.548
2007 Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry. 64: 633-47. PMID 17548746 DOI: 10.1001/Archpsyc.64.6.633  0.487
2006 Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2033-46. PMID 16641947 DOI: 10.1038/Sj.Npp.1301072  0.566
2004 Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 72: 29-39. PMID 15531405 DOI: 10.1016/J.Schres.2004.09.007  0.612
2004 Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry. 56: 301-7. PMID 15336511 DOI: 10.1016/J.Biopsych.2004.06.023  0.604
2003 Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophrenia Bulletin. 29: 45-55. PMID 12908660 DOI: 10.1093/Oxfordjournals.Schbul.A006990  0.533
Show low-probability matches.